Stockreport

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders [Yahoo! Finance]

Virax Biolabs Group Limited - Ordinary Shares  (VRAX) 
PDF in the Company's current public valuation despite its balance sheet strength, debt-free position, recent financing and operational progress. LONDON April 14, 2026 /PRN [Read more]